SORT BY Relevancy
Eli Lilly and Quintiles entered into a co-investment partnership to develop a new solution using computer-assisted designs that emphasize the improvement of scientific and operational outcomes of clinical trials. The results were shared at the DPharm 2013 event and project leaders from both companies will talk to our host Craig Lipset on how this formation is doing a year later. Also joining Craig is Jeff Lee, CEO, Omniscience to discuss featured news and trends in clinical trial innovation and in particular mobile applications.
Craig Lipset, MBA, Head of Clinical Innovation, R&D, Pfizer, Inc.
Jeffrey Kasher, PhD, VP & COO, Eli Lilly & Company
Jeff Lee, CEO, Omniscience Mobile
Rick Sax, MD, SVP Clinical Design & Reporting Services, Quintiles
A panel of executives from leading pharma and the venture capital community at the DPharm Disruptive Innovations conference recently awarded the 2013 Disruptive Innovator of the Year title to Medidata Solutions and Spaulding Clinical Research. They won for their collaboration on a novel study evaluating the impact of mobile and cloud-based technology on patient engagement for improved health outcomes in the diabetes community.
Host Craig Lipset, Head of Clinical Innovation, R&D at Pfizer speaks with Dr. Andrew Lee of Sanofi on key takeaways from the 2013 DPharm conference along with the CEOs of the winning companies to learn more about their collaboration.
Andrew Lee, MD, SVP, Deputy Head of Clinical Sciences & Operations, Sanofi
Glen De Vries, President of Medidata Solutions
Randy Spaulding, Founder and CEO of Spaulding Clinical Research
Helen Blair Simpson, MD, PhD, Director of the Anxiety Disorders Clinic and the Center for OCD and Related Disorders at the New York State Psychiatric Institute/Columbia University Medical Center
Moira Rynn, MD, Director of the Division of Child & Adolescent Psychiatry and Pediatric Anxiety and Mood Research Clinic at the New York State Psychiatric Institute/Columbia University Medical Center
Dr. Helen Blair Simpson and Dr. Moira Rynn will talk about what we have learned so far in clinical research and what we are doing now for the patients of today and tomorrow. They will address what we have learned about biological research and the brain mechanisms related to OCD symptoms. Finally, they will discuss updates on clinical trials that they are currently conducting for adult, adolescent and child OCD patients.
For more information on OCD treatment and research opportunities for adults, please visit our clinic website at www.Columbia-OCD.org and our treatment study website at http://ocdtreatmentstudy.com/ or call us at 212-543-5462.
For more information on OCD treatment and research opportunities for children and adolescents, please visit our website http://columbiapsychiatry.org/pamrc or call us at 212-543-5592.
Please join me on Wednesday evening, March 7th at 5 PM PST on "The Global Voice". This week's show will be dedicated to some exciting ALS breakthroughs in research and clinical trials , a registry that many PALS may not be aware of and an opportunity to call in and ask your questions about what's happening and how you can get involved. Please call in to the show at 347-884-8988 and please stay on the switchboard for your call to be received. Our guests will
Join host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer with guests Joe Kim, Clinical Operations Director, Shire and Dr. Hugo Stevenson, physician and serial entrepreneur, as they discuss innovation transforming the clinical trial space to include: * Mobile technology and apps * Clinical trials and diversity * Google Glass for health * Investigator database sharing * Key motivations for innovators and moreThe opinions shared by Craig and our guests are those of the speakers and do not necessarily reflect the opinions of their employers.
Join us in a discussion on serving patients in clinical trials.
Making clinical trials more accessible for patients Emerging technologies / iPads and informed consent Disruption Headlines in the news Host:
Craig Lipset, MBA Head of Clinical Innovation, R&D, Pfizer Inc.
Andreas Koester, MD, PhD VP, Clinical Trial Innovation & External Alliances, Janssen
Anthony Costello, CEO, Mytrus
Drs. Christopher Gallen, CEO at SK BioPharmaceuticals and Mitchell Katz, Executive Director, Medical Research Operations at Purdue Pharma, in a candid conversation on navigating the complexities of Global Clinical Trials and addressing topics including: Why global trials? Why are global trials so expensive? How are companies re-thinking global trials? What's happening with global outsourcing? Thoughts on emerging markets and patient recruitment What can we do to help mitigate the risks of global trials?
This radio show will discuss all of the research conducted with the fire service by the UL Firefighter Safety Research Institute. Guests from fire departments that have served on the technical panels of the research will share their perspectives and how they have incorporated the results into their departments.Host Steve Kerber is the Director of the UL Firefighter Safety Research Institute. He has led fire service research and education in the areas of ventilation, structural collapse, and fire dynamics. A 13-year veteran of the fire service, with most of his service at the College Park Fire Department in Prince George's County Maryland where he served at ranks up through Deputy Chief. He currently serves on the Advisory Board of Fire Engineering and the Fire Department Instructors Conference. Steve has also been appointed to the rank of Honorary Battalion Chief by the FDNY.
Special guest: Michael Silverman
In early August we interviewed Michael Silverman of Silverman Research about 'The Future of Research' research! In this show he is coming back to discuss their findings.
Hosts: Jo Dodds & Jo Moffatt
Back channel: https://plus.google.com/communities/118419210283831602780/events
Somewhere between statistician and entertainer lies Tom Webster. Tom Webster is Vice President, Strategy and Marketing of Edison Research with nearly 20 years of experience in media research, marketing strategy and product development. Webster’s duties at Edison also include strategic development and leading Edison’s new media research efforts. An expert in qualitative and quantitative research techniques, Webster has directed hundreds of studies in nearly every major U.S. market and worldwide. Don't miss our interview this week with Tom. Tom will be joining us on the Edge of the Web radio podcast discussing topics including infographics, data analysis, his iOS7 upgrade (kidding - he did it while we recorded the interview), and some incredible research that Edison will be releasing in the next week on Internet Radio usage trends.
Tom's blog is BrandSavant and he's a fantastic guest. He's quick witted and isn't shy about providing his opinion. He's a great person to follow on Twitter and Facebook as well!
I sent an affidavit of facts:disclaimer for the NSA's PRISM Research in August 2013 and it has been over 30 days and they did not refut each paragraph. They did not respond. Their silence is asquiescence:quiet admission and passive consent. Silent is asquiescence. We are aking for remedies/reliefs for all involuntary or unwitting human subjects and even private matters in America and International.
We demand that ALL UNCONSTITUTIONAL ACTIVITIES & ACTIONS CEASE & DESIST IMMEDIATE!
The Key Study Personnel you have until 3:00 pm EST on Monday, October 7, 2013 to complete the form for leniency. Afterwards, we will seek immediate arrests.
Join Host Live Chats
- Psychic Tapestry (13 chatters)
- Rosebud Rez (7 chatters)
- Callywood (6 chatters)
- Carlotta Chatwood (6 chatters)
- Habs360 (5 chatters)
- The Jackson 2 (4 chatters)
- The Life Oasis Empowerment Radio (3 chatters)
- Christian Defence League (3 chatters)
- DeAngelo Starnes (1 chatters)
- Charles Internatl House Music (1 chatters)
- John Christopher Sutton (1 chatters)
- Omega Ministry Group (1 chatters)